Cipla doubles remdesivir production to meet 'unprecedented' demand

"We have scaled up the production of remdesivir by 2x from the last wave of the pandemic," Cipla said in a statement. "Given the unprecedented demand for the drug, we have now further ramped up our capacities through our network."

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3wSS5JC
via IFTTT